Detecting Genetic Changes in Breast Cancer
Author Information
Author(s): Mezzelani A, Alasio L, Bartoli C, Bonora M G, Pierotti M A, Rilke F, Pilotti S
Primary Institution: Istituto Nazionale per lo Studio e la Cura dei Tumouri
Hypothesis
Combining fine-needle aspiration and fluorescence in situ hybridization can improve the detection of c-erbB2/neu amplification in breast cancer patients.
Conclusion
The combination of fine-needle aspiration and fluorescence in situ hybridization provides more reliable results for detecting c-erbB2/neu amplification than traditional immunocytochemistry.
Supporting Evidence
- FISH was successful in 58 out of 60 cases.
- 24 cases showed c-erbB2/neu amplification.
- 3 cases were negative for amplification despite being positive by ICC.
- The study highlights the reliability of FNA and FISH for genetic analysis.
Takeaway
Doctors can use a special test to find important genes in breast cancer that help decide the best treatment.
Methodology
Fine-needle aspiration samples were analyzed using fluorescence in situ hybridization to detect c-erbB2/neu amplification.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website